Öppna denna publikation i ny flik eller fönster >>Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk och translationell biologi.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk och translationell biologi.
Department of Cell Biology, Duke University, NC, Durham, United States.
Department of Cell Biology, Duke University, NC, Durham, United States.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia; ARC Centre of Excellence for Innovations in Peptide and Protein Science, the University of Queensland, QLD, Brisbane, Australia.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia; ARC Centre of Excellence for Innovations in Peptide and Protein Science, the University of Queensland, QLD, Brisbane, Australia.
Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain; Department of Biomedical Sciences, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia.
Institute for Molecular Bioscience, the University of Queensland, QLD, Brisbane, Australia; Centre for Microscopy and Microanalysis, the University of Queensland, QLD, Brisbane, Australia.
Visa övriga...
2025 (Engelska)Ingår i: Cell Reports, ISSN 2639-1856, E-ISSN 2211-1247, Vol. 44, nr 6, artikel-id 115789Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Caveolae are specialized plasma membrane domains with a unique lipid composition. Lipid peroxidation has recently been implicated in triggering caveola disassembly, releasing cavin proteins to regulate oxidative-stress-associated cellular processes, particularly ferroptosis. Here, we investigated how specific lipids influence caveola formation and their response to oxidative stress. A targeted screening of pro-ferroptotic enzymes identified ACSL4, a key enzyme in synthesizing polyunsaturated fatty acid (PUFA)-linked phospholipids, and ether phospholipid biosynthesis enzymes as critical regulators of caveola formation. Membrane-incorporated omega-6 PUFAs promoted caveola formation, while their displacement by omega-3 PUFAs or monounsaturated fatty acids disrupted this process. Importantly, oxidation of omega-6 PUFA chains in phosphatidylethanolamine (PE) triggered caveola disassembly during lipid peroxidation, potentially by affecting cavin-membrane interactions. These findings unveil a new model for caveola formation and signaling, linking caveola dynamics to ferroptosis with pro-ferroptotic lipids as essential caveolar components and key control points for caveola disassembly under oxidative stress.
Ort, förlag, år, upplaga, sidor
Elsevier, 2025
Nyckelord
ACSL4, cCaveolae, CP: Cell biology, fFerroptosis, lLipids, MUFA, pPlasmalogens, PUFA
Nationell ämneskategori
Cell- och molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-239822 (URN)10.1016/j.celrep.2025.115789 (DOI)40478736 (PubMedID)2-s2.0-105007064091 (Scopus ID)
Forskningsfinansiär
EU, FP7, Sjunde ramprogrammet, FP7-2007-201EU, FP7, Sjunde ramprogrammet, 101071784
2025-06-172025-06-172025-06-17Bibliografiskt granskad